Evidence map›Paper›PMID 39557932›Full record

ArticleScientific reports2024

L-shaped association of plasma low-density lipoprotein cholesterol with atrial fibrillation recurrence after catheter ablation: a prospective cohort study.

Huiming Zou, Qianghui Huang, Qianwei Huang, Bingchao Hu, Wenhao He, Zirong Xia, Zongcai Duan, Guoqing Li, Jianxin Hu, Jinzhu Hu and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Molecular phenotyping of atrial remodeling in atrial fibrillation usingThe international journal of cardiovascular imaging · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Huiming Zou *Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Qianghui Huang *Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Qianwei HuangDepartment of Cardiovascular Medicine, The Third People's Hospital of Pingxiang, Pingxiang, China.
Bingchao HuDepartment of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Wenhao HeDepartment of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Zirong XiaDepartment of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Zongcai DuanDepartment of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Guoqing LiDepartment of Cardiovascular Medicine, The Affiliated Hospital of Jiujiang University, Jiujiang, China.
Jianxin HuDepartment of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China. 932349266@qq.com.
Jinzhu HuDepartment of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China. hujinzhu1983@sina.com.
Biming ZhanDepartment of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China. drzhanbiming@163.com.

Funding

2021 SKY Imaging Research Fund of the Chinese International Medical Foundation 01he Second Affiliated Hospital Of Nanchang University Funding Program 2021efyC07Jiang Xi Province Science Foundation for Distinguished Young Scholar 20202ACBL216001Jiangxi Province's Main Discipline Academic and Technical Leader Training Program - Leading Talent Project 20204BCJ22029National Natural Science Foundation of China 82060075National Natural Science Foundation of China NSFC 81860070 and 82070350Natural Science Foundation of Jiangxi Province 20212BAB216057On-campus cultivation plan of Nanchang University PY201927The Second Affiliated Hospital Of Nanchang University Funding Program 2021efyC01
6 · The paper itself

Abstract

The association between plasma low-density lipoprotein cholesterol (LDL-C) and atrial fibrillation (AF) recurrence after catheter ablation remains unclear. We aimed to assess the relationship between preprocedural LDL-C and the AF recurrence in patients undergoing catheter ablation. The cohort study consecutively included AF patients who underwent de novo catheter ablation between April 2021 and January 2023 in the Second Affiliated Hospital of Nanchang University in Jiangxi Province, China. Patients were divided into quartiles based on their baseline fasting LDL-C level (Q1-Q4). Multivariable Cox proportional hazards models were used to evaluate the relationship between LDL-C and AF recurrence. Our analysis included the use of a generalized additive model and smooth curve fitting (penalized spline method), and two-piecewise Cox proportional hazards models, to address the nonlinearity between preprocedural LDL-C and AF recurrence. A total of 482 AF patients with de novo catheter ablation were enrolled, with a median follow-up period of 15.00 months, AF recurrence occurred in 96 (19.92%) patients. The relationship between preprocedural LDL-C and AF recurrence after ablation presented as an L-shape, and the inflection point for the curve was found at the LDL-C level of 3.20 mmol/L (Log likelihood ratio P = 0.031). The hazard ratios (HR) [(95% confidence intervals (CI)] for AF recurrence were 0.50 (0.33-0.74) and 2.11 (0.76-5.89) to the left and right of the inflection point, respectively. Lower LDL-C level is associated with increased AF recurrence risk after catheter ablation were consistent across all subgroups.

Indexed as

Atrial FibrillationCatheter AblationCholesterol, LDLRecurrenceAgedChinaFemaleHumansMaleMiddle AgedProportional Hazards ModelsProspective StudiesRisk FactorsCholesterol, LDLAtrial fibrillationCohort studyLow-density lipoprotein cholesterolRadiofrequency catheter ablationRecurrence

Identifiers

PMID39557932
PMCPMC11574032

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.